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The Ethics of Infection Control: Philosophical Frameworks
Charles S. Bryan, MD; Theresa J. Call, BS; Kevin C. Elliott, PhD

Recent developments that are relevant to the ethics of infection control include the patient safety movement, the appearance of new diseases
(notably, severe acute respiratory syndrome) that pose threats to healthcare workers, data confirming the suspicion that infection control
measures such as isolation may compromise patient care, and, in philosophy, renewed interest in virtue ethics and communitarianism. We
review general ethical frameworks and relevant vocabulary for infection control practitioners and hospital epidemiologists. Frameworks for
the ethics of infection control resemble those of public health more than those of clinical medicine but embrace elements of both. The
optimum framework, we suggest, takes into account a virtue-based communitarianism. The virtue ethics movement stresses the need to
consider not only rules and outcomes but also the character of the individual(s) involved. Communitarianism emphasizes the well-being
and values of local communities, best determined by shared, democratic decision making among stakeholders. Brief discussions of 15
consecutive cases illustrate the extent to which the daily practice of infection control poses problems heavily freighted with ethical overtones.
Infect Control Hosp Epidemiol 2007; 28:1077-1084

An ethical problem exists when there is uncertainty about the
best course of action from a moral perspective. Most problems
encountered by infection control practitioners (ICPs) and hospital epidemiologists carry ethical overtones, although these
might not be readily apparent to those involved. In 1996,
Herwaldt1 reviewed infection control ethics and offered a
practical framework for decision making. She pointed out
that among the 4 well-known principles of biomedical ethics
articulated by Beauchamp and Childress2 (beneficence, nonmaleficence, justice, and autonomy; Appendix), the ethics of
infection control emphasizes justice, whereas clinical ethics
underscores patient autonomy. Little has been written on this
topic in recent years. However, there has been a burgeoning
literature on the closely related ethics of public health.3-17
Meanwhile, in general philosophy, there has been a resurgence
of interest in virtue ethics,18,19 which stresses the need to
consider not only rules and outcomes but also the character
of the individual(s) involved, and a renewed interest in communitarianism, which places special focus on community values and the common good.20-22
Our purpose in this brief review is to familiarize ICPs and
hospital epidemiologists with some general philosophical
frameworks and a selected vocabulary for decision making
at the local level. In the text that follows, we introduce terms
useful for framing ethical dilemmas (Appendix and Figure
1). These frameworks and terms are illustrated in the context
of 15 representative problems encountered at our institution
(Table). We suggest that the optimum framework for infection

control ethics takes into account a virtue-based communitarianism pursued with the goal of decreasing the incidence
of healthcare-related infections and problem pathogens to an
irreducible minimum.

h i s t o r i c al o v e rv i e w
In 1970, infection control came into its own as a formal
discipline with an international conference sponsored by the
Center for Disease Control (as it was then known).23 That
same year, the term “bioethics” was coined in 2 radically
different contexts. The politician Sargent Shriver, during a
conversation with Kennedy relatives that took place in his
Bethesda, Maryland, living room, used “bioethics” to denote
the application of moral philosophy to problems in clinical
medicine. Also in 1970, Van Renssaelaer Potter, an American
biochemist, used “bioethics” to denote a science of human
survival in which biological facts must be taken into account.24,25 Since 1970, bioethics, including clinical ethics,
has thrived almost exclusively in the sense used by Shriver,
and its focus has been mainly, though not exclusively, on
individual well-being. ICPs and hospital epidemiologists will,
however, recognize the relevance of Potter’s definition as it
applies to problems such as bioterrorism, pandemic influenza,
the increasing resistance of common pathogens to available
drugs, and the emergence of new diseases, such as severe
acute respiratory syndrome (SARS). ICPs and hospital epidemiologists will also note that, aside from a period of intense
debate during the late 1980s and early 1990s about the ethics
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an d d e c i s i o n m ak i n g

figure 1. A wide variety of ethical concepts and terms can be
brought to bear on problems encountered in the daily practice of
infection control. Terms emphasized in this review are shown in
capital letters. See Appendix for details.

of managing human immunodeficiency virus infection,26,27
bioethicists have largely ignored infectious diseases, concentrating instead on headline-grabbing topics such as euthanasia, futility, truth telling, and stem-cell research.28,29
Most ICPs and hospital epidemiologists enter infection
control from clinical medicine, a discipline in which the welfare of individual patients nearly always trumps broader social
concerns. In contrast, infection control measures, like public
health measures, often infringe on individual rights and liberties; examples include disease surveillance and reporting,
the use of isolation precautions, and the restricted use of
certain antimicrobial agents. Infection control ethics, like
public health ethics, requires balancing the utilitarian goal of
promoting public health against the libertarian goal of protecting individual rights, such as privacy and freedom of
movement. It has, for example, been shown that infection
control measures—most notably, the barrier precautions inherent to patient isolation—can negatively affect the welfare
of individual patients by causing nurses and physicians to
make fewer bedside visits.30,31 Restricting antimicrobial agents
limits physicians’ options for individual patients. The appearance of SARS renews issues raised during the early years
of the human immunodeficiency virus infection epidemic,
such as the duty of healthcare workers (HCWs) to assume
personal risks on behalf of individual patients and the community.32 To assist ICPs and hospital epidemiologists in making these difficult decisions, and with reference to the Appendix and Figure 1, we will briefly review 3 frameworks for
ethical and political reasoning, several strategies for balancing
benefits and burdens, and a working approach to decision
making in infection control.

Discussions of ethical problems tend to be long, tedious, and
inconclusive because parties bring to the table competing
ethical frameworks in which they remain firmly entrenched.
The most common frameworks involve rights- or duty-based
(ie, deontological) ethics and results-based (ie, consequentialist) ethics. Utilitarianism is a well-known example of a
results-based ethical theory. It judges actions by the extent
to which they promote the overall well-being (ie, utility) of
society or, as the theory’s great proponent Jeremy Bentham
(1748-1832) famously put it, promote “the greatest happiness
of the greatest number.” Libertarianism and liberalism, which
are often derived from duty-based ethical theories, judge actions by the extent to which they respect individuals’ rights
even when such respect may compromise society’s well-being
overall. Libertarianism focuses especially on negative rights,
such as privacy and freedom from government interference.
In addition to negative rights, liberalism also supports positive
rights to such basic goods as education and health care. (“Liberalism” as used here differs from the common usage in the
United States, where it is used as a synonym for the political
left; in most countries, liberals belong to the political right
or center.) Let us briefly examine how deontological and
consequentialist ethical theories might clash in infection control, as they do in public health.7-9,32
A deontologist might argue that infection control strategies
such as disease reporting, screening, and patient isolation compromise individual rights and freedom of movement. Such
consequentialist approaches, the deontologist might worry, pay
insufficient attention to distributive justice and respect for individuals. A consequentialist might counter that promoting the
interests of individuals (as is common in libertarianism and
liberalism) compromises the greater good of society, and that
good citizenship matters more than individual rights and entitlements. The deontologist might next point out that the
consequentialist cannot anticipate the full range of potential
harms resulting from a given infection control strategy, much
less state their probabilities. The consequentialist would respond that the deontologist’s rules (principles from which
rights and duties are derived) may be insensitive to particular
circumstances. Also, who makes the rules? An emerging viewpoint in philosophy holds that such conflicts might be ameliorated by calling into play a third framework: communitarianism reinforced by virtue ethics.20-22,33
A renaissance in virtue ethics began in 1954 when English
philosopher Elizabeth Anscombe argued that ethical theories
focusing on duty (deontology) or results (consequentialism)
tend to neglect virtue, character, and the emotions.34 Virtue
ethics rests on the premise that, in weighing an action, we
must consider not only the relevant duties and results but
also the character of the actor (or, in technical terms, the
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table

Fifteen Cases That Illustrate Ethical Problems in Infection Control

Case
Case 1
Case 2

Case 3
Case 4

Case 5
Case 6
Case 7
Case 8
Case 9

Case 10

Case 11
Case 12
Case 13

Case 14
Case 15
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Problem
Should a postpartum woman being treated for a breast abscess due to MRSA be allowed to visit her infant in a busy
neonatal intensive care unit in which MRSA has not yet emerged as a significant problem?
Should the new tetanus, diphtheria, and pertussis vaccine be offered to all HCWs and not just those who work with infants
and young children, at a cost of nearly $250,000 to a financially strapped hospital system? (For a preliminary approach to
this problem, see Figure 2.)
What steps should be taken by ICPs and hospital epidemiologists to prevent inappropriate use of surveillance data in the
wake of new state legislation mandating public availability of these data?
Given that 3 of her patients have had MRSA infections within the past year and that nasal culture reveals she has MRSA
carriage, should an implant surgeon cancel scheduled procedures at the first symptoms of a common cold because of the
possibility of the “cloud adult” phenomenon?
How should ICPs and hospital epidemiologists respond to administrators who insist that the costs of maintaining negative
air pressure in a dusty construction area adjacent to the hospital’s linen processing unit would be prohibitive?
What statement, if any, should ICPs and hospital epidemiologists make to a pandemic preparedness committee concerning
the duties of HCWs to care for patients with emerging deadly diseases such as SARS and avian influenza?
How should the infection control department address a proposal to install a decorative waterfall in the lobby of a children’s
hospital given the potential risk of Legionella infection?
How should the infection control department address a request from the quality assurance department to promote
improved hand hygiene and observe the use of precautions among physicians?
Should the infection control committee endorse a recommendation from another committee that all patients admitted to
the hospital have nasal cultures for MRSA performed, given the problematic implications that positive results might have
for individuals?
How should the infection control department respond to the hospital administration’s mandate (after the visit from a
consultant) that zero is the only acceptable rate for central catheter–related bloodstream infection and ventilatorassociated pneumonia?
Which hospital personnel should be given priority in the distribution of influenza vaccine in the event of an approaching
pandemic of influenza and a real or perceived vaccine shortage?
Should use of the antibiotic linezolid be liberalized rather than continuing a requirement for written justification based on
the potential development of resistance?
Should vancomycin be used only for those cases of Clostridium difficile colitis with systemic toxicity or that have failed to
respond to metronidazole, on the basis of expert opinion that vancomycin is perhaps more effective than metronidazole,
especially in cases of severe disease?59
How should the infection control department best respond to a complaint by hospital personnel that certain radiologists
and cardiologists do not observe optimum sterile technique when performing procedures?
Should a patient with known bronchiectasis and multiple cultures positive for acid-fast bacilli and cultures positive for
Mycobacterium avium-intracelluare over the past 10 years, and who now has a smear positive for acid-fast bacilli and a
new, small lower lobe infiltrate, be kept under respiratory isolation precautions until a current culture specimen has been
shown not to contain Mycobacterium tuberculosis?

note.

HCW, healthcare worker; ICP, infection control practitioner; MRSA, methicillin-resistant Staphylococcus aureus; SARS, severe acute respiratory
syndrome.

agent; see Appendix). An emerging perspective holds virtue
ethics to be complementary to deontological and consequentialist frameworks. What, then, do we mean by “virtue”?
In classic philosophy, virtue was often understood as aretê,
or excellence in function. The 7 classic virtues consist of the
4 cardinal virtues from Plato’s Republic (practical wisdom,
justice, temperance, and courage) and the 3 transcendent
virtues from St. Paul in 1 Corinthians 13:13 (faith, hope, and
love). Some maintain that these 7 virtues, when combined
with their associated traits and derived virtues, suffice for the
individual project of building character.35-38 These 7 virtues
serve, in a sense, as “ethical primary colors.” For example,
humility can be viewed as temperance combined with justice,

resolve as courage combined with hope, and honesty as justice
combined with courage and faith.
Practical wisdom and love are, respectively, the key virtues
for competence and caring—the twin pillars of clinical medicine. ICPs and hospital epidemiologists need practical wisdom to guide them in making decisions in the face of uncertainty, justice to seek a balance between individual rights
and the common good, temperance to seek restraint in the
use of healthcare resources, courage to engage busy and politically powerful physicians and administrators in dialogue,
and the transcendent virtues—faith, hope, and love—to assist
them toward actions that are supererogatory, ie, above and
beyond the call of duty. The virtuous ICP or hospital epi-
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demiologist strives constantly to improve his or her performance, character, and credibility. In the healthcare environment, ICPs and hospital epidemiologists are unique in that
they bring (or should bring) special expertise in the recognition and prevention of infections. From this position of
epistemic authority they should share with their colleagues
not only the most recent data and knowledge but also the
limitations of current understanding.39,40 The virtuous ICP or
hospital epidemiologist exercises his or her epistemic authority
wisely to promote virtuous behavior intrinsic to the practice
of medicine: adherence to measures known to reduce the likelihood of disease transmission, including the observance of
precautions and the maintenance of scrupulous hand hygiene.41
Communitarianism is, in brief, an emerging ethical and
political philosophy, closely allied with virtue ethics, whereby
stakeholders formulate policies based on their shared vision
of the optimum society. We should emphasize “shared,” because communitarianism functions best in the context of a
participatory (not merely representative) democracy. Communitarianism is best viewed as a way of thinking that honors
the ability of people to seek mutually satisfactory solutions
to their common ethical problems. An infection control committee that functions well, with its broad representation of
stakeholders (physicians, nurses, administrators, pharmacists,
laboratory personnel, environmental services, and many others), thus represents an exercise in communitarianism. ICPs
therefore have the opportunity to work with others toward
defining what constitutes an optimum communitarian vision
of a safe hospital environment that also respects individual
rights and freedoms.
The shared values developed by the community of ICPs
and hospital epidemiologists can and should promote conflict
resolution. These values should not be exempt from outside
evaluation and critique, and indeed ICPs and hospital epidemiologists should recognize that others may legitimately
hold quite different perspectives (see the definitions of moral
absolutism, moral pluralism, and moral relativism in the Appendix). We believe that a virtue-based communitarianism
steeped in the shared values of ICPs, hospital epidemiologists,
and other stakeholders constitutes a logical starting point for
institutionwide ethical deliberation.

th e d oc tr i ne o f d o u b l e e ffe c t
an d th e p rec a u t io n a ry prin c ip l e
ICPs and hospital epidemiologists should be aware of 2 additional principles pertaining to ethical issues in infection
control: the doctrine of double effect and the precautionary
principle. Both of these principles, which are discussed and
debated at length in the biomedical and general ethics literature,42-52 involve trade-offs between beneficence (doing
good) and nonmaleficence (avoiding harm).
The doctrine of double effect justifies the possibility of
harming certain individuals to bring about other goods. This

doctrine stipulates 4 conditions for justifying an action that
may cause harm: (1) the action itself must be morally good
or at least indifferent, (2) the bad effect should not be intended but merely foreseen as a possibility, (3) the good effect
must not be produced by means of the bad effect, and (4)
there must be a proportionality between the good and bad
effects that justifies the good effect.42 In the context of infection control, for example, one might appeal to the doctrine
of double effect to justify barrier precautions for the sake of
protecting others, despite the possibility that some patients
may receive less attention from nurses and physicians as an
inadvertent side effect.
The precautionary principle, in its simplest form, justifies
anticipatory preventive action despite incomplete scientific
evidence.13,47 For example, John Snow invoked the precautionary principle when he advised removing the handle from
the public water pump on Broad Street to halt the 1854
London cholera epidemic. Yet how much scientific evidence
must one have to invoke the precautionary principle? How
much do we know about the risks, and how much do we
know about the costs of preventive measures, including harm
to certain individuals? (We can only imagine the wrath of
inconvenienced individuals had John Snow been wrong about
the Broad Street pump.) The precautionary principle, at its
best, summons us to a “best practices” approach to participatory and democratic decision making under uncertainty.
To summarize ideas covered to this point, we suggest that
a virtue-based communitarianism should complement infection control policies and procedures based on rules (deontology) and results (consequentialism). ICPs and hospital epidemiologists should (1) exercise their epistemic authority
wisely to (2) seek communitarian solutions that address conflicts between deontological and utilitarian concerns with
careful consideration of the local context, in an effort to (3)
advance the social and moral good of decreasing the incidence
of healthcare-related infections and their associated problem
pathogens to an irreducible minimum. As part and parcel of
this communitarian approach, ICPs and hospital epidemiologists should promote those virtues (that is, the various
character traits and behavioral strengths) that reduce the likelihood of disease transmission. The doctrine of double effect
and the precautionary principle illustrate types of concerns
that ICPs and hospital epidemiologists may need to address
when analyzing moral problems. Let us now review briefly how
ICPs and hospital epidemiologists optimally make decisions.

working approaches to ethical
d e c i s i o n m ak i n g
Kass5 proposed the following questions for evaluating the
extent to which public health measures simultaneously promote not only the general good but also social justice and
protection of individual liberties, and the questions seem
equally applicable to infection control. (1) What are the spe-
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cific goals of a proposed program? (2) How effective is the
program for achieving its stated goals? (3) What are the
known or potential burdens of the program? (4) Can the
burdens be minimized, and are there alternative approaches?
(5) Is the program being implemented fairly? (6) How can
the benefits and burdens of the program be fairly balanced?
ICPs and hospital epidemiologists should strive toward helping everyone in their healthcare system to feel confident that
their programs will promote the welfare of patients (and
HCWs), that the measures are minimally burdensome, that
a fair procedure has determined the extent of any given problem, and that the benefits of a proposed program override
competing desiderata. To illustrate these considerations and
other concerns that come into play (Appendix), let us consider briefly 15 cases that arose in the daily practice of infection control at our institutions (Table).
ICPs and hospital epidemiologists will perceive that some
of these problems invite prima facie solutions. For example,
in Case 4, the surgeon could be treated with mupirocin; in
Case 5, reference could be made to hospital accreditation
standards; and in Case 7, the issue could be referred to design
engineers. Virtuous ICPs will nevertheless demonstrate their
epistemic authority with humility, recognizing the complexity
of problems that initially seem straightforward. The downsides to denying the postpartum woman access to her newborn infant (Case 1) and to keeping the patient with bronchiectasis on respiratory isolation (Case 15) illustrate the
doctrine of double effect. To what extent, if any, does the
postpartum woman, gowned and gloved, with her abscess
drained and dressed, pose a danger to others (Case 1)? What
is the likelihood that the new acid-fast bacillus culture will
reveal Mycobacterium tuberculosis when multiple cultures over
the past 10 years have consistently shown M. avium-intracelluare (Case 15)? The potential for litigation tempts ICPs
and hospital epidemiologists, as it does other HCWs, to brush
aside the golden rule (what they would want for themselves
if they were the patient) in deference to policies and procedures (deontic pronouncements). Writing and disseminating a well-reasoned opinion based on clinical facts, relevant
literature, and appropriate ethical frameworks constitutes a
better approach. A documented judgment that incorporates
up-to-date information and shows sensitivity to competing
ethical concerns seldom, if ever, constitutes the grounds for a
successful theory of negligence; attorneys call this due diligence.
Some of the cases cited in the Table likewise elicit prima
facie responses that promote infection control measures at
the expense of the healthcare system as a whole. Offering the
tetanus, diphtheria, and pertussis vaccine to all HCWs, as
opposed to just those who work directly with pediatrics patients (Case 2, which is illustrated in Figure 2); raising the
costs of new construction (Case 5); and opposing decorative
fountains (Case 7) all have sound theoretical justifications,
but are they beneficial to the healthcare system and its constituencies? What data support these decisions? A growing
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body of data supports obtaining nasal specimens to check for
methicillin-resistant Staphylococcus aureus (MRSA) in patients admitted to intensive care units, but are such cultures
warranted for all patients admitted to the hospital (Case 9)?
Identifying individuals as MRSA carriers brings into play the
doctrine of double effect and the precautionary principle.
Here, ICPs and hospital epidemiologists should remember
the clinical motto, “Don’t order a test unless you plan to act
on it.” Can we minimize the stigma of being labeled an MRSA
carrier? Can we deal with the likelihood that the number of
patients under contact precautions will be quadrupled, and
that such patients can anticipate, according to 3 studies and
a recent review, a 50% reduction in visits by nurses and
physicians?53 Issues of antibiotic restriction (Cases 12 and 13)
raise questions about the moral defensibility of denying patients what we would want for ourselves. Many jeremiads
against overuse of antibiotics fail to address adequately the
issue, “Is it good enough for Mom?” Nevertheless, there are
obviously some situations in which responsibility for the
common good overrides prima facie obligations to individual
patients.
Most ICPs and hospital epidemiologists, harkening back
to nineteenth-century breakthroughs by the likes of Ignaz
Semmelweis, Oliver Wendell Holmes, and Joseph Lister, consider their most basic ongoing challenge to be promotion of
such general measures as hand hygiene, standard precautions,
and aseptic technique (Case 8). Addressing the suspect behaviors of individuals requires courage (Case 14). ICPs and
hospital epidemiologists also address issues that challenge the
supererogatory ideals of HCWs, the concept of health care
as a higher calling in which service to others transcends selfinterest.54 Should ICPs and hospital epidemiologists proclaim
the duty of HCWs to care for patients with deadly conditions,

figure 2. A “4-quadrant” approach to ethical deliberation involves (1) dividing the facts and concepts to be addressed into 4
categories, (2) listing facts and concepts without discussion, and (3)
group discussion with the aim of finding a mutually satisfactory
solution. In this figure, this approach is applied to the question,
“Should the new tetanus, diphtheria, and pertussis vaccine be offered
to all healthcare workers?”(Case 2, Table). ACIP, Advisory Committee on Immunization Practices.
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such as SARS, or for patients known or suspected to be victims of bioterrorism (Case 6)? How and to what extent should
ICPs and hospital epidemiologists recommend priorities for
vaccination in the face of shortages (Case 11)?
In these and similar dilemmas that crop up in daily practice, ICPs and hospital epidemiologists recognize that national
guidelines and recommendations sometimes fail to offer tidy
solutions. It may comfort ICPs and hospital epidemiologists
to know that some philosophers feel that, in most situations,
ethical precepts and principles are of less importance than
the particular details of a case (see the definition of particularism in the Appendix).55 To summarize the procedure suggested by Soskolne56 and endorsed by Herwaldt,1,57 the process
of arriving at decisions in infection control should include a
careful review of relevant facts, values, and external factors,
as well as awareness of the relevant ethical frameworks (Figure
2). Acknowledging the give and take between and among
deontological, consequentialist, and communitarian frameworks can, potentially, help stakeholders recognize why they
differ and, in recognizing their differences, seek common
ground.58

new c h a lle n g e s
W. Edwards Deming, in his System of Profound Knowledge,
argued that leaders must constantly put their credibility on
the line. The current patient safety movement will tax both
the leadership ability and the epistemic authority (credibility)
of ICPs and hospital epidemiologists. Mandatory reporting
of surveillance data (Case 3) will tempt administrators to misuse such data to gain competitive advantage. Administrators
may in turn tempt ICPs and hospital epidemiologists to underreport data, as indicated by one administrator’s impression
that zero is the only acceptable rate for ventilator-associated
pneumonia and central catheter–related bloodstream infection
(Case 10). This may change the entire paradigm of infection
control surveillance, which heretofore has emphasized liberal
case criteria so that sufficient data can be obtained to determine
whether problems exist. At our institutions, we witness not
only other committees’ concerns with infection control issues
(eg, Cases 8 and 9) but also the creation of new committees,
such as a Central Venous Catheter Committee, a VentilatorAssociated Pneumonia Committee, and an MRSA Committee.
We have chosen not to address power differentials but rather
to formulate proactive recommendations for definitions of disease and collaboration in and among institutions. These new
challenges reinforce our conviction that a virtue-based communitarianism is essential to ensuring the safety of current and
future patients in the difficult and changing context of contemporary medical practice.
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ap p e n d i x
This Appendix defines general concepts and relevant terms
used in this article.
Frameworks for Ethics
Deontological ethics. A theory according to which the morality of actions is based on their accordance with duty and
respect for persons (developed influentially by Immanuel
Kant).
Consequentialist ethics. “Results-based” ethics, according
to which the morality of actions depends on their consequences (with utilitarianism being a particularly influential
version).
Virtue ethics. “Character ethics,” a theory that focuses on
developing agents (that is, persons who act or have the power
or authority to act) with virtuous character traits.
Utilitarianism. A consequentialist ethical theory according to which the morality of actions is determined by the
total utility (classically interpreted as happiness) that they
produce.
Liberalism. A political viewpoint focused on neutrality
among competing conceptions of the good and on individual
rights and liberties, including positive rights to goods such
as health care.
Libertarianism. A political viewpoint (sometimes known
as classical liberalism) that accepts only negative rights to be
free of outside interference (such as force, fraud, or theft).
Communitarianism. A political and ethical viewpoint that
emphasizes community values as the ground for ethical reasoning and the good of communities as a primary focus.
Perspectives on the Universality of Ethical Conclusions
Moral absolutism. The perspective that there is only one
true moral system; contrasted with relativism (see below).
Moral pluralism. The perspective that there are multiple,
equally fundamental moral principles and systems that are
in conflict with one another.
Moral relativism. The perspective that all moral principles
and systems are valid only relative to a particular culture (conventionalism) or to the choices of an individual (subjectivism).
Some Relevant Principles
Principles of clinical ethics. Four foundational principles
articulated by Beauchamp and Childress2: beneficence (the
duty to do good), nonmaleficence (the duty to avoid doing
harm), justice (the duty to treat equals equally), and autonomy (the duty to respect the patient’s ability to control his
or her life).
The doctrine of double effect. A principle for weighing
good and bad consequences of an action, focusing on the
distinction between intended and foreseen effects.
The precautionary principle. A principle with diverse for-

the ethics of infection control

mulations, focusing on the legitimacy of taking action to prevent harm in the absence of complete scientific information.
Some Nouns and Adjectives
Deontic. Of or pertaining to duty.
Epistemic. Of or pertaining to knowledge.
Epistemic authority. Expertise with respect to a particular
body of knowledge.
Moral particularism. The position that moral analysis
should rest not on general moral principles but rather on a
careful examination of the salient considerations in particular
cases.
Prima facie. “At first glance”; refers to duties that hold all
else being equal, in the absence of overriding considerations.
Rights. Claims that obligate others to benefit an individual (positive rights) or to abstain from hindering an individual (negative rights).
Supererogatory. “Above and beyond the call of duty,” applied to good actions that go beyond what is required by duty.
Virtues. Excellences in function that promote the good.
The 4 cardinal virtues (from Plato) are wisdom, justice, temperance, and courage; the 3 transcendent virtues (from Saint
Paul, 1 Corinthians 13:13) are faith, hope, and love.

Address reprint requests to Charles S. Bryan, MD, Two Medical Park, Suite
502, Columbia, SC 29203 (cbryan@gw.mp.sc.edu).
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